Embla Medical Statistics
Total Valuation
Embla Medical has a market cap or net worth of DKK 12.42 billion. The enterprise value is 15.42 billion.
Market Cap | 12.42B |
Enterprise Value | 15.42B |
Important Dates
The next estimated earnings date is Tuesday, April 29, 2025.
Earnings Date | Apr 29, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Embla Medical has 426.81 million shares outstanding. The number of shares has increased by 1.51% in one year.
Current Share Class | n/a |
Shares Outstanding | 426.81M |
Shares Change (YoY) | +1.51% |
Shares Change (QoQ) | -3.47% |
Owned by Insiders (%) | 0.04% |
Owned by Institutions (%) | 73.83% |
Float | 161.22M |
Valuation Ratios
The trailing PE ratio is 25.24 and the forward PE ratio is 19.80. Embla Medical's PEG ratio is 0.90.
PE Ratio | 25.24 |
Forward PE | 19.80 |
PS Ratio | 2.02 |
PB Ratio | 2.22 |
P/TBV Ratio | n/a |
P/FCF Ratio | 19.37 |
P/OCF Ratio | n/a |
PEG Ratio | 0.90 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 12.86, with an EV/FCF ratio of 24.05.
EV / Earnings | 31.36 |
EV / Sales | 2.50 |
EV / EBITDA | 12.86 |
EV / EBIT | 18.29 |
EV / FCF | 24.05 |
Financial Position
The company has a current ratio of 1.90, with a Debt / Equity ratio of 0.64.
Current Ratio | 1.90 |
Quick Ratio | 1.03 |
Debt / Equity | 0.64 |
Debt / EBITDA | 3.06 |
Debt / FCF | 5.61 |
Interest Coverage | 4.89 |
Financial Efficiency
Return on equity (ROE) is 9.28% and return on invested capital (ROIC) is 5.80%.
Return on Equity (ROE) | 9.28% |
Return on Assets (ROA) | 4.86% |
Return on Invested Capital (ROIC) | 5.80% |
Return on Capital Employed (ROCE) | 8.55% |
Revenue Per Employee | 1.52M |
Profits Per Employee | 121,112 |
Employee Count | 4,061 |
Asset Turnover | 0.58 |
Inventory Turnover | 2.29 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -16.12% in the last 52 weeks. The beta is 0.55, so Embla Medical's price volatility has been lower than the market average.
Beta (5Y) | 0.55 |
52-Week Price Change | -16.12% |
50-Day Moving Average | 31.69 |
200-Day Moving Average | 32.40 |
Relative Strength Index (RSI) | 45.73 |
Average Volume (20 Days) | 65,911 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Embla Medical had revenue of DKK 6.16 billion and earned 491.84 million in profits. Earnings per share was 1.15.
Revenue | 6.16B |
Gross Profit | 3.85B |
Operating Income | 819.42M |
Pretax Income | 652.37M |
Net Income | 491.84M |
EBITDA | 993.48M |
EBIT | 819.42M |
Earnings Per Share (EPS) | 1.15 |
Balance Sheet
The company has 620.67 million in cash and 3.60 billion in debt, giving a net cash position of -2.98 billion or -6.98 per share.
Cash & Cash Equivalents | 620.67M |
Total Debt | 3.60B |
Net Cash | -2.98B |
Net Cash Per Share | -6.98 |
Equity (Book Value) | 5.62B |
Book Value Per Share | 13.11 |
Working Capital | 1.35B |
Cash Flow
In the last 12 months, operating cash flow was 836.08 million and capital expenditures -194.73 million, giving a free cash flow of 641.35 million.
Operating Cash Flow | 836.08M |
Capital Expenditures | -194.73M |
Free Cash Flow | 641.35M |
FCF Per Share | 1.50 |
Margins
Gross margin is 62.55%, with operating and profit margins of 13.31% and 7.99%.
Gross Margin | 62.55% |
Operating Margin | 13.31% |
Pretax Margin | 10.59% |
Profit Margin | 7.99% |
EBITDA Margin | 16.13% |
EBIT Margin | 13.31% |
FCF Margin | 10.41% |
Dividends & Yields
Embla Medical does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -1.51% |
Shareholder Yield | -1.51% |
Earnings Yield | 3.96% |
FCF Yield | 5.16% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Embla Medical has an Altman Z-Score of 3.17.
Altman Z-Score | 3.17 |
Piotroski F-Score | n/a |